-+ 0.00%
-+ 0.00%
-+ 0.00%

SEED RECEIVES FDA RARE PEDIATRIC DISEASE AND ORPHAN DRUG DESIGNATIONS FOR LEAD ONCOLOGY ASSET RBM39 DEGRADER AND ENTERS STRATEGIC TRANSACTIONS WITH NEW INVESTORS

Reuters·01/28/2025 12:00:01

Please log in to view news